BrainsWay Ltd (BWAY)
10.28
+0.05
(+0.49%)
USD |
NASDAQ |
Nov 04, 16:00
10.30
+0.02
(+0.19%)
After-Hours: 20:00
BrainsWay Revenue (Quarterly): 10.00M for June 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 10.00M |
March 31, 2024 | 9.095M |
December 31, 2023 | 9.029M |
September 30, 2023 | 8.302M |
June 30, 2023 | 7.829M |
March 31, 2023 | 6.625M |
December 31, 2022 | 6.033M |
September 30, 2022 | 5.168M |
June 30, 2022 | 8.006M |
March 31, 2022 | 7.97M |
December 31, 2021 | 8.47M |
September 30, 2021 | 8.061M |
June 30, 2021 | 7.005M |
March 31, 2021 | 6.121M |
December 31, 2020 | 7.066M |
September 30, 2020 | 6.014M |
June 30, 2020 | 4.82M |
March 31, 2020 | 4.157M |
December 31, 2019 | 6.292M |
September 30, 2019 | 5.932M |
June 30, 2019 | 5.695M |
Date | Value |
---|---|
March 31, 2019 | 5.182M |
December 31, 2018 | 4.772M |
September 30, 2018 | 4.295M |
June 30, 2018 | 3.726M |
March 31, 2018 | 3.605M |
December 31, 2017 | 3.602M |
September 30, 2017 | 3.016M |
June 30, 2017 | 2.379M |
March 31, 2017 | 2.148M |
December 31, 2016 | 2.876M |
September 30, 2016 | 3.407M |
June 30, 2016 | 2.753M |
March 31, 2016 | 2.488M |
December 31, 2015 | 2.258M |
September 30, 2015 | 1.823M |
June 30, 2015 | 1.446M |
March 31, 2015 | 1.273M |
December 31, 2014 | 1.196M |
September 30, 2014 | 0.84M |
June 30, 2014 | 0.7242M |
March 31, 2014 | 0.7045M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
4.157M
Minimum
Mar 2020
10.00M
Maximum
Jun 2024
7.162M
Average
7.066M
Median
Dec 2020
Revenue (Quarterly) Benchmarks
Compugen Ltd | 6.702M |
Pluri Inc | 0.096M |
BioLine Rx Ltd | 5.393M |
Can Fite Biofarma Ltd | 0.155M |
BiomX Inc | -- |
Revenue (Quarterly) Related Metrics
Net Income (Quarterly) | 0.60M |
Total Expenses (Quarterly) | 9.419M |
EPS Diluted (Quarterly) | 0.04 |
Enterprise Value | 123.57M |
Gross Profit Margin (Quarterly) | 75.33% |
Profit Margin (Quarterly) | 6.00% |
Earnings Yield | 0.33% |
Operating Earnings Yield | 0.44% |
Normalized Earnings Yield | 0.3338 |